Skip to content. | Skip to navigation

Sections
IMPaCT Trial

Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer.

Make a Donation

Help the APGI and ensure our work continues. Make a donation today.

Get Email Updates
Familial Cancer Cohort

If you would like to be involved in the project please click here to find out more.

 

APGI Symposium 2012

Scientist, health care professionals and members of the public from around Australia and the the world attended the APGI's annual Symposium on Saturday.

The 3rd annual APGI Clinical and Scientific Symposium was a great success. We would like to give a big thank you to all our speakers who presented interesting findings, ideas and a great overview of the research of the Australian Pancreatic Genome Initiative (APGI).

Richard Gibbs (Human Genome Sequencing Center, Baylor College of Medicine, USA) presented the new developments that are occurring in genome sequencing, whilst the steps being taken to apply this plethora of next generation sequencing data was presented by John McPherson (Cancer Genomics Center, Ontario Institute of Cancer Research, Canada).

APGI's progress was presented by the leaders of the research team, Sean Grimmond and Andrew Biankin. PhD students from within the research group on the other hand presented some of the new research projects that are underway, such as the Circulating DNA Study and the Adjuvant Radiotherapy Project.

The issue of ethics in research and how researchers should go about returning the results of sequencing was tackled by Nik Zeps and Jack Goldblatt, leading to great discussion between researchers and clinicians.

Finally, we would also like to thank all who attended and look forward to seeing you next year for more exciting and up-to-date talks on research into Pancreatic Cancer within the APGI.